Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-24 @ 10:32 PM
NCT ID:
NCT01327235
Eligibility Criteria:
Inclusion Criteria:
* Histological or cytological diagnosis of thoracic or abdominal tumor
* At least medium amount of malignant pleural effusion or ascites
* ECOG Performance Status 0-2
* Life expectancy ≥ 2 months
* Adequate hematologic, cardiac, renal, and hepatic function
* No major surgery within 4 weeks prior to this study
* Written informed consent
Exclusion Criteria:
* Patients with central nervous system (CNS) metastases
* Evidence of bleeding diathesis, serious infection
* Evidence of myocardial infarction, unstable angina or cardiac insufficiency
* Presence of serious COPD and/or respiratory failure
* Allergic to study drug
* Pregnant or lactating women
* Participation in other clinical trials within 30 days prior to this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01327235
Study Brief:
Protocol Section:
NCT01327235